OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
-2.77%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$535M
AUM Growth
+$535M
(-11%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
59.08%
Holding
57
New
9
Increased
13
Reduced
14
Closed
9
Top Buys
| 1 |
Semler Scientific
SMLR
|
$28.2M |
| 2 |
Keros Therapeutics
KROS
|
$4.65M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$4.24M |
| 4 |
Amicus Therapeutics
FOLD
|
$3.06M |
| 5 |
CMRX
Chimerix, Inc.
CMRX
|
$2.48M |
Top Sells
| 1 |
ESSA Pharma
EPIX
|
$8.12M |
| 2 |
Seres Therapeutics
MCRB
|
$5.96M |
| 3 |
GeneDx Holdings
WGS
|
$5.24M |
| 4 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$3.82M |
| 5 |
Kezar Life Sciences
KZR
|
$3.79M |
Sector Composition
| 1 | Healthcare | 98.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
GeneDx Holdings
WGS
$3.65B
| – | – |
-373,828
| Closed | -$5.24M |
|
52
Pharvaris
PHVS
$1.41B
| – | – |
-79,837
| Closed | -$1.49M |
|
|
53
Seres Therapeutics
MCRB
$162M
| – | – |
-250,000
| Closed | -$5.96M |
|
|
54
Kezar Life Sciences
KZR
$28.5M
| – | – |
-697,800
| Closed | -$3.79M |
|
|
55
ESSA Pharma
EPIX
$11.2M
| – | – |
-284,050
| Closed | -$8.12M |
|
56
Cardiff Oncology
CRDF
$130M
| – | – |
-463,000
| Closed | -$3.08M |
|
57
Cidara Therapeutics
CDTX
$1.61B
| – | – |
-73,351
| Closed | -$148K |
|